Scholarly publications and presentations by Rochester Regional Health's Internal Medicine department authors.
Submissions from 2026
9-15-2026 Demographics and clinical implications of a global bibliographic profile for the hypertrophic cardiomyopathy literature over 66 years (1960-2025), Ahmed Sayed, Rochester Regional Health, Ethan J. Rowin, Martin S. Maron, et al.
9-1-2026 Cerebral embolic protection devices for transcatheter aortic valve replacement: A meta-analysis and trial sequential analysis, Hossam Elbenawi, Ibrahim Hassan, Mahmoud Shaaban Abdelgalil, et al.
9-1-2026 Comparing the diagnostic performance of 19-gauge and 22-gauge needles in endoscopic ultrasound-guided liver biopsy: a systematic review and meta-analysis, Muhammad Ali Butt, Rahul Karna, Sheza Malik, Rochester Regional Health, et al.
9-1-2026 Hydrocortisone Use for Septic Shock in Patients With CKD, Parth Dhamelia, Hashane Abeyagunawardene, Rajshekhar A. Kore, et al.
9-1-2026 Prognosis of Patients with Lung Cancer Admitted to the Intensive Care Unit: A Systematic Review and Meta-Analysis, Ahmed Elkhapery, Rochester Regional Health, Hazem Taifour, Rochester Regional Health, Chengu Niu, Rochester Regional Health, et al.
8-1-2026 ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 ABCL-669: Reversible Locked-in–Like Syndrome From Ifosfamide Encephalopathy in Relapsed T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, Mutasim Idriss, Rochester Regional Health, ELrazi Ali, Mohamed Hegazi, et al.
8-1-2026 ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis, Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, et al.
8-1-2026 ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis, Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, et al.
8-1-2026 Acute Interstitial Nephritis after Single Dose of Ketorolac, Ishan Jani, Rochester Regional Health; Arjun Sekar, Rochester Regional Health; and Sergey Brodsky
8-1-2026 ALL-1229: Clinical Impact of Tumor Lysis Syndrome in Acute Leukemia: A Comparative Analysis of Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia, Jawad Ahmed, Farheen Malik, Osama Mohiuddin, et al.
8-1-2026 AML-1359: Global, Regional, and National Macroeconomic Burden of Acute Myeloid Leukemia: A Value-of-Lost-Welfare Analysis of 184 Countries, 2023, Yojan Chandra Reddy Vennapusa, Deep Sanjaykumar Sangani, Rutvij Bharatsinh Solanki, et al.
8-1-2026 AML-1700: Leukemia Mortality Among Patients With Substance Use Disorder in the United States, 1999–2020: A Population-Based Analysis of Trends and Disparities, Parth Desai, Rutvij Bharatsinh Solanki, Deep Sanjaykumar Sangani, et al.
8-1-2026 AML-1733: Trends in Acute Myeloid Leukemia Mortality Among Female Patients in the United States, 1999–2020: A Population-Based Analysis of Average Annual Percent Change, Krishna Sajeev, Rochester Regional Health, Sai Varun Gadde, FNU Bhuvan, et al.
8-1-2026 AML-1737: Pneumonia as a Contributing Cause of Death in Acute Myeloid Leukemia Patients: A 22-Year Population-Based Analysis of Trends in the United States, 1999–2020, Rutvij Solanki, Parth Desai, Yojan Chandra Reddy Vennapusa, et al.
8-1-2026 AML-1739: Racial Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018–2024: A Nationwide Trend Analysis Across 15 Racial Groups, Sai Varun Gadde, Krishna Sajeev, Rochester Regional Health, FNU Bhuvan, et al.
8-1-2026 CLL-046: Predictors and Outcomes of Major Cardiovascular Events in Hospitalized Chronic Lymphocytic Leukemia Patients (2017–2021), Toluwani Balogun, Rochester Regional Health, Purva Shah, Rochester Regional Health, Vasudha Garg, Rochester Regional Health, et al.
8-1-2026 CLL-1558: Outcomes of Venetoclax Retreatment After Prior Frontline Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis, Mutasim Idriss, Rochester Regional Health, Summiya Nasim, Muhammad Junaid, et al.
8-1-2026 Disparities in Palliative Care Utilization in Metastatic Triple-negative Breast Cancer: A National Cancer Database Study, Cher Ying Foo, Rochester Regional Health, Ojasav Sehrawat, Rochester Regional Health, Akshjot Puri, et al.
8-1-2026 MCL-668: Infectious Complications in Patients With Mantle Cell Lymphoma Treated With CAR-T Therapy: A Real-World TriNetX Analysis, Anushree Venkatesh Murthy, Rochester Regional Health, Adithya Nagendran, Rochester Regional Health, Logesh Durairaj, Rochester Regional Health, et al.
8-1-2026 MM-1033: Efficacy and Safety of Chimeric Antigen Receptor T-cell Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 MM-1033: Efficacy and Safety of Chimeric Antigen Receptor T-cell Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 MM-1400: Disseminated Intravascular Coagulation in Multiple Myeloma: A Nationwide Analysis of Mortality, Organ Failure, and Healthcare Utilization, Jawad Ahmed, Dua Azim, Rochester Regional Health, Abdul Ghani Iqbal, et al.
8-1-2026 MM-1692: Global, Regional, and National Macroeconomic Burden of Multiple Myeloma: An Age-Stratified Value-of-Lost-Welfare Analysis of 184 Countries, 2023, Hardik Dineshbhai Desai, Digantkumar Patel, Aditya Ahuja, et al.